دورية أكاديمية
أعرض في EDS

Clinical practice in COVID-19: The most frequently asked questions to infectious diseases specialists.

التفاصيل البيبلوغرافية
العنوان: Clinical practice in COVID-19: The most frequently asked questions to infectious diseases specialists.
المؤلفون: Borges MASB; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brazil; Serviço de Infectologia, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, GO, Brazil. Electronic address: moarasb@ufg.br., Guilarde AO; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brazil; Serviço de Infectologia, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, GO, Brazil; Centro de Reabilitação e Readaptação Dr. Henrique Santillo-CRER, Goiânia, GO, Brazil., Tomich LGMM; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brazil; Hospital Estadual de Doenças Tropicais, Goiânia, GO, Brazil; Universidade de Rio Verde - campus Aparecida de Goiânia, Aparecida de Goiânia, GO, Brazil., Turchi MD; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brazil.
المصدر: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2021 Nov-Dec; Vol. 25 (6), pp. 101648. Date of Electronic Publication: 2021 Nov 08.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Editora Country of Publication: Brazil NLM ID: 9812937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1678-4391 (Electronic) Linking ISSN: 14138670 NLM ISO Abbreviation: Braz J Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: 2010- : Rio de Janeiro : Elsevier Editora
Original Publication: Salvador, Bahia, Brazil : Contexto, c1997-
مواضيع طبية MeSH: COVID-19* , Communicable Diseases* , Physicians*, Humans ; SARS-CoV-2 ; Vaccination
مستخلص: Since the emergence of the disease caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2) - COVID-19 - in late December 2019, a vast number of publications on the subject appeared in peer-reviewed journals and preprints. Despite the significant amount of available information, infectious disease physicians are requested to solve questions from colleagues, patients, and relatives on a daily basis. Here, we aim to describe the evidence supporting the answers for frequently asked questions, based on a literature review. We created a web-based questionnaire which was distributed to a group of 70 infectious disease specialists and medical residents, asking what questions and issues they most frequently faced. The 10 most frequent questions guided the topics for a narrative review. We provide evidence and consensus-based information on subjects such as infection and transmission, isolation, management of COVID-19 confirmed cases, reinfection, clinical-therapeutic management, vaccination, and antibodies post-infection/vaccination. Correctly clarifying doubts and providing clear information to physicians, patients, and family members helps to better manage COVID-19 in the community and the hospital settings.
Competing Interests: Conflicts of interest The authors declare no conflict of interest.
(Copyright © 2021 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.)
References: Nature. 2020 Oct;586(7830):578-582. (PMID: 32731258)
Clin Infect Dis. 2021 Nov 2;73(9):e2841-e2842. (PMID: 33043962)
Emerg Infect Dis. 2021;27(6):1737-1740. (PMID: 33871331)
Clin Microbiol Infect. 2021 Jan;27(1):61-66. (PMID: 33010444)
Lancet. 2021 Mar 27;397(10280):1204-1212. (PMID: 33743221)
Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840. (PMID: 33315061)
Clin Infect Dis. 2021 May 18;72(10):e533-e541. (PMID: 32820807)
JAMA Intern Med. 2021 Oct 1;181(10):1407-1408. (PMID: 34048531)
BMJ Open. 2020 Aug 16;10(8):e039652. (PMID: 32801208)
N Engl J Med. 2021 Feb 25;384(8):693-704. (PMID: 32678530)
Lancet Infect Dis. 2021 Jan;21(1):52-58. (PMID: 33058797)
Emerg Infect Dis. 2021 May;27(5):1446-1453. (PMID: 33797393)
Nat Commun. 2021 Jan 11;12(1):267. (PMID: 33431879)
JAMA. 2021 Jun 22;325(24):2457-2465. (PMID: 33956048)
Euro Surveill. 2020 Jan;25(3):. (PMID: 31992387)
N Engl J Med. 2021 Aug 26;385(9):790-802. (PMID: 34351721)
Lancet Microbe. 2021 Jun;2(6):e240-e249. (PMID: 33778792)
JAMA. 2021 May 18;325(19):2013-2014. (PMID: 33843975)
Lancet. 2021 May 01;397(10285):1637-1645. (PMID: 33933206)
J Infect. 2021 Mar;82(3):e35-e37. (PMID: 33248218)
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. (PMID: 33029620)
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. (PMID: 32442256)
Clin Infect Dis. 2020 Apr 27;:. (PMID: 32338708)
Lancet Public Health. 2021 May;6(5):e335-e345. (PMID: 33857453)
Clin Infect Dis. 2020 Sep 12;:. (PMID: 32918466)
JAMA. 2020 Jun 9;323(22):2245-2246. (PMID: 32391855)
Nat Med. 2020 Nov;26(11):1691-1693. (PMID: 32929268)
Nature. 2020 May;581(7809):465-469. (PMID: 32235945)
Thromb Res. 2018 Apr;164 Suppl 1:S62-S69. (PMID: 29703486)
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. (PMID: 33188730)
J Med Virol. 2020 Nov;92(11):2286-2287. (PMID: 32347980)
Science. 2021 May 21;372(6544):815-821. (PMID: 33853970)
Lancet Microbe. 2021 Jan;2(1):e13-e22. (PMID: 33521734)
N Engl J Med. 2021 Mar 4;384(9):795-807. (PMID: 33306283)
Crit Care Explor. 2020 Nov 16;2(11):e0280. (PMID: 33225306)
Nature. 2021 Mar;591(7851):639-644. (PMID: 33461210)
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163. (PMID: 32356867)
Nature. 2021 Dec;600(7889):512-516. (PMID: 34544114)
Lancet Haematol. 2021 Jul;8(7):e524-e533. (PMID: 33930350)
Science. 2021 Feb 5;371(6529):. (PMID: 33408181)
EClinicalMedicine. 2021 May;35:100861. (PMID: 33937733)
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S138-S145. (PMID: 33045075)
Clin Chim Acta. 2020 Jun;505:190-191. (PMID: 32145275)
J Thromb Haemost. 2020 Aug;18(8):1859-1865. (PMID: 32459046)
Science. 2020 Aug 14;369(6505):806-811. (PMID: 32434945)
BMJ. 2021 Aug 20;374:n2015. (PMID: 34417194)
JAMA. 2021 Apr 27;325(16):1620-1630. (PMID: 33734299)
PLoS One. 2020 Dec 31;15(12):e0244126. (PMID: 33382764)
BMJ. 2021 May 13;373:n1088. (PMID: 33985964)
N Engl J Med. 2020 Nov 5;383(19):1813-1826. (PMID: 32445440)
Lancet Infect Dis. 2020 Sep;20(9):1004-1005. (PMID: 32645295)
Science. 2021 Mar 25;:. (PMID: 33766944)
Nature. 2021 Jul;595(7867):426-431. (PMID: 34126625)
Lancet. 2021 Mar 27;397(10280):1161-1163. (PMID: 33743219)
Commun Med (Lond). 2021 Nov 15;1:48. (PMID: 35602219)
JAMA Intern Med. 2021 May 1;181(5):672-679. (PMID: 33625463)
JAMA. 2020 Apr 21;323(15):1502-1503. (PMID: 32105304)
J Infect. 2021 Mar;82(3):399-406. (PMID: 33589297)
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):753-758. (PMID: 34014909)
Clin Infect Dis. 2021 May 4;72(9):1682-1683. (PMID: 32621739)
فهرسة مساهمة: Keywords: COVID-19; COVID-19 vaccines; Practice management; Quarantine; SARS-CoV-2; Transmission; Viral shedding
تواريخ الأحداث: Date Created: 20211118 Date Completed: 20211223 Latest Revision: 20220824
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8572702
DOI: 10.1016/j.bjid.2021.101648
PMID: 34793712
قاعدة البيانات: MEDLINE
الوصف
تدمد:1678-4391
DOI:10.1016/j.bjid.2021.101648